Sung-Hsin Kuo

19PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersHumoural immunology and immunochemistryAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 12, 2026
Increased CCR5 expression in lymphoma cells and M2 macrophages is associated with poor prognosis in primary intestinal diffuse large B-cell lymphoma.

|Aug 05, 2026
Diversified cell origin of Helicobacter pylori eradication-responsive gastric diffuse large B-cell lymphomas.

|Jan 16, 2026
ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant Therapy.

Po-Han Lin, Li-Wei Tsai, Chiao Lo

|Dec 27, 2023
Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era.

Wei-Li Ma, Ruey-Long Hong, Pei-Jen Lou

|May 11, 2023
MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.

Sung-Hsin Kuo, Ming-Feng Wei, Yi-Hsuan Lee

|Feb 23, 2023
First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma.

Ming Yao, Shu-Lang Liao, Chung-Wu Lin

Pageof 4

Frequent Collaborators

5 joint publications

Chung-Wu Lin

3 joint publications

Ann-Lii Cheng

2 joint publications

Chiun-Sheng Huang

1 joint publications

Jenny Ling-Yu Chen